Using Central IRBs for Multicenter Clinical Trials in the United States

Research institutions differ in their willingness to defer to a single, central institutional review board (IRB) for multicenter clinical trials, despite statements from the FDA, OHRP, and NIH in support of using central IRBs to improve the efficiency of conducting trials. The Clinical Trials Transf...

Descripción completa

Detalles Bibliográficos
Autores principales: Flynn, Kathryn E., Hahn, Cynthia L., Kramer, Judith M., Check, Devon K., Dombeck, Carrie B., Bang, Soo, Perlmutter, Jane, Khin-Maung-Gyi, Felix A., Weinfurt, Kevin P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559741/
https://www.ncbi.nlm.nih.gov/pubmed/23383026
http://dx.doi.org/10.1371/journal.pone.0054999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559741/
https://www.ncbi.nlm.nih.gov/pubmed/23383026
http://dx.doi.org/10.1371/journal.pone.0054999

Ejemplares similares